Research programme: G protein-coupled receptor modulators - Pfizer/Lexicon Genetics
Alternative Names: GPCR modulators - Pfizer/LexiconLatest Information Update: 16 Mar 2022
At a glance
- Originator Arena Pharmaceuticals; Lexicon Genetics
- Developer Arena Pharmaceuticals; Lexicon Pharmaceuticals
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 11 Mar 2022 Arena Pharmaceuticals has been acquired and merged into Pfizer
- 31 May 2006 No development reported - Preclinical for Undefined in USA (unspecified route)
- 03 Feb 2003 This programme is still in active development